AL, F., JK, Z., JT, S., MX, Y., MR, N., XW, W., . . . X, Q. (2011). CD16+ monocytes in breast cancer patients: Expanded by monocyte chemoattractant protein-1 and may be useful for early diagnosis. Clinical and experimental immunology, 164(1), 57. https://doi.org/10.1111/j.1365-2249.2011.04321.x
Chicago Style (17th ed.) CitationAL, Feng, et al. "CD16+ Monocytes in Breast Cancer Patients: Expanded by Monocyte Chemoattractant Protein-1 and May Be Useful for Early Diagnosis." Clinical and Experimental Immunology 164, no. 1 (2011): 57. https://doi.org/10.1111/j.1365-2249.2011.04321.x.
MLA (9th ed.) CitationAL, Feng, et al. "CD16+ Monocytes in Breast Cancer Patients: Expanded by Monocyte Chemoattractant Protein-1 and May Be Useful for Early Diagnosis." Clinical and Experimental Immunology, vol. 164, no. 1, 2011, p. 57, https://doi.org/10.1111/j.1365-2249.2011.04321.x.